Convergence Investment Partners LLC Sells 3,246 Shares of Universal Health Services, Inc. (NYSE:UHS)

Convergence Investment Partners LLC lowered its position in shares of Universal Health Services, Inc. (NYSE:UHS) by 36.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,563 shares of the health services provider’s stock after selling 3,246 shares during the quarter. Convergence Investment Partners LLC’s holdings in Universal Health Services were worth $1,045,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in UHS. Norges Bank purchased a new position in shares of Universal Health Services during the fourth quarter valued at approximately $67,964,000. Invesco Ltd. boosted its position in Universal Health Services by 25.6% in the fourth quarter. Invesco Ltd. now owns 1,241,340 shares of the health services provider’s stock worth $222,721,000 after purchasing an additional 253,385 shares during the last quarter. Freestone Grove Partners LP bought a new position in Universal Health Services in the 4th quarter valued at $41,155,000. AQR Capital Management LLC increased its position in shares of Universal Health Services by 59.4% during the 4th quarter. AQR Capital Management LLC now owns 590,389 shares of the health services provider’s stock valued at $105,928,000 after purchasing an additional 219,942 shares during the last quarter. Finally, Bridgewater Associates LP increased its holdings in Universal Health Services by 119.1% during the fourth quarter. Bridgewater Associates LP now owns 322,163 shares of the health services provider’s stock worth $57,802,000 after buying an additional 175,131 shares during the last quarter. Institutional investors and hedge funds own 86.05% of the company’s stock.

Universal Health Services Stock Performance

NYSE:UHS opened at $164.50 on Thursday. The stock’s fifty day moving average is $181.94 and its 200 day moving average is $181.20. The firm has a market capitalization of $10.69 billion, a PE ratio of 9.23, a PEG ratio of 0.71 and a beta of 1.28. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.23 and a current ratio of 1.32. Universal Health Services, Inc. has a fifty-two week low of $153.99 and a fifty-two week high of $243.25.

Universal Health Services (NYSE:UHS) last posted its quarterly earnings results on Monday, April 28th. The health services provider reported $4.84 earnings per share for the quarter, beating the consensus estimate of $4.36 by $0.48. Universal Health Services had a net margin of 7.44% and a return on equity of 17.79%. The firm had revenue of $4.10 billion during the quarter, compared to the consensus estimate of $4.16 billion. During the same quarter in the previous year, the firm posted $3.70 earnings per share. The company’s revenue was up 6.7% on a year-over-year basis. On average, sell-side analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.

Universal Health Services Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 16th. Investors of record on Tuesday, September 2nd will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $0.80 annualized dividend and a yield of 0.49%. Universal Health Services’s dividend payout ratio (DPR) is 4.49%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Baird R W lowered shares of Universal Health Services from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Guggenheim started coverage on shares of Universal Health Services in a research note on Wednesday, April 9th. They issued a “buy” rating and a $208.00 price target for the company. Bank of America downgraded shares of Universal Health Services from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $215.00 to $185.00 in a research note on Wednesday, July 16th. Morgan Stanley initiated coverage on Universal Health Services in a research note on Wednesday, March 26th. They issued an “equal weight” rating and a $200.00 target price on the stock. Finally, Robert W. Baird reissued a “neutral” rating and set a $224.00 price objective (down from $274.00) on shares of Universal Health Services in a research report on Tuesday, April 15th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Universal Health Services presently has an average rating of “Hold” and an average target price of $221.85.

Insider Buying and Selling at Universal Health Services

In other Universal Health Services news, Director Maria Ruderman Singer sold 1,097 shares of the business’s stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $191.48, for a total transaction of $210,053.56. Following the sale, the director owned 7,884 shares in the company, valued at approximately $1,509,628.32. The trade was a 12.21% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 16.40% of the company’s stock.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.